86 related articles for article (PubMed ID: 15611080)
21. Endocytosis of hepatitis C virus non-enveloped capsid-like particles induces MAPK-ERK1/2 signaling events.
Katsarou K; Lavdas AA; Tsitoura P; Serti E; Markoulatos P; Mavromara P; Georgopoulou U
Cell Mol Life Sci; 2010 Jul; 67(14):2491-506. PubMed ID: 20358251
[TBL] [Abstract][Full Text] [Related]
22. Backbone Modification Provides a Long-Acting Inverse Agonist of Pathogenic, Constitutively Active PTH1R Variants.
Liu S; Daley EJ; Tran LM; Yu Z; Reyes M; Dean T; Khatri A; Levine PM; Balana AT; Pratt MR; Jüppner H; Gellman SH; Gardella TJ
J Am Chem Soc; 2024 Mar; 146(10):6522-6529. PubMed ID: 38417010
[TBL] [Abstract][Full Text] [Related]
23. Informatic deconvolution of biased GPCR signaling mechanisms from in vivo pharmacological experimentation.
Maudsley S; Martin B; Janssens J; Etienne H; Jushaj A; van Gastel J; Willemsen A; Chen H; Gesty-Palmer D; Luttrell LM
Methods; 2016 Jan; 92():51-63. PubMed ID: 25986936
[TBL] [Abstract][Full Text] [Related]
24. Skeletal diseases caused by mutations in
Csukasi F; Bosakova M; Barta T; Martin JH; Arcedo J; Barad M; Rico-Llanos GA; Zieba J; Becerra J; Krejci P; Duran I; Krakow D
Front Cell Dev Biol; 2022; 10():963389. PubMed ID: 36726589
[TBL] [Abstract][Full Text] [Related]
25. SRC signaling is crucial in the growth of synovial sarcoma cells.
Michels S; Trautmann M; Sievers E; Kindler D; Huss S; Renner M; Friedrichs N; Kirfel J; Steiner S; Endl E; Wurst P; Heukamp L; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Cancer Res; 2013 Apr; 73(8):2518-28. PubMed ID: 23580575
[TBL] [Abstract][Full Text] [Related]
26. Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases.
Moritz A; Li Y; Guo A; Villén J; Wang Y; MacNeill J; Kornhauser J; Sprott K; Zhou J; Possemato A; Ren JM; Hornbeck P; Cantley LC; Gygi SP; Rush J; Comb MJ
Sci Signal; 2010 Aug; 3(136):ra64. PubMed ID: 20736484
[TBL] [Abstract][Full Text] [Related]
27. Spp24 derivatives stimulate a Gi-protein coupled receptor-Erk1/2 signaling pathway and modulate gene expressions in W-20-17 cells.
Zhao KW; Murray EJ; Murray SS
J Cell Biochem; 2015 May; 116(5):767-77. PubMed ID: 25501958
[TBL] [Abstract][Full Text] [Related]
28. c-Jun N-terminal kinase phosphorylation of heterogeneous nuclear ribonucleoprotein K regulates vertebrate axon outgrowth via a posttranscriptional mechanism.
Hutchins EJ; Szaro BG
J Neurosci; 2013 Sep; 33(37):14666-80. PubMed ID: 24027268
[TBL] [Abstract][Full Text] [Related]
29. Ankrd26 gene disruption enhances adipogenesis of mouse embryonic fibroblasts.
Fei Z; Bera TK; Liu X; Xiang L; Pastan I
J Biol Chem; 2011 Aug; 286(31):27761-8. PubMed ID: 21669876
[TBL] [Abstract][Full Text] [Related]
30. Targeting CDK1 promotes FLT3-activated acute myeloid leukemia differentiation through C/EBPα.
Radomska HS; Alberich-Jordà M; Will B; Gonzalez D; Delwel R; Tenen DG
J Clin Invest; 2012 Aug; 122(8):2955-66. PubMed ID: 22797303
[TBL] [Abstract][Full Text] [Related]
31. Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.
Engelman JA; Chen L; Tan X; Crosby K; Guimaraes AR; Upadhyay R; Maira M; McNamara K; Perera SA; Song Y; Chirieac LR; Kaur R; Lightbown A; Simendinger J; Li T; Padera RF; García-Echeverría C; Weissleder R; Mahmood U; Cantley LC; Wong KK
Nat Med; 2008 Dec; 14(12):1351-6. PubMed ID: 19029981
[TBL] [Abstract][Full Text] [Related]
32. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.
Kawagoe T; Sato S; Matsushita K; Kato H; Matsui K; Kumagai Y; Saitoh T; Kawai T; Takeuchi O; Akira S
Nat Immunol; 2008 Jun; 9(6):684-91. PubMed ID: 18438411
[TBL] [Abstract][Full Text] [Related]
33. Genetic evidence for the role of Erk activation in a lymphoproliferative disease of mice.
Miyaji M; Kortum RL; Surana R; Li W; Woolard KD; Simpson RM; Samelson LE; Sommers CL
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14502-7. PubMed ID: 19667175
[TBL] [Abstract][Full Text] [Related]
34. The Molecular Mechanisms Underlying the Systemic Effects Mediated by Parathormone in the Context of Chronic Kidney Disease.
Maranduca MA; Cozma CT; Clim A; Pinzariu AC; Tudorancea I; Popa IP; Lazar CI; Moscalu R; Filip N; Moscalu M; Constantin M; Scripcariu DV; Serban DN; Serban IL
Curr Issues Mol Biol; 2024 Apr; 46(5):3877-3905. PubMed ID: 38785509
[TBL] [Abstract][Full Text] [Related]
35. The Intricacies of Renal Phosphate Reabsorption-An Overview.
Walker V
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731904
[TBL] [Abstract][Full Text] [Related]
36. Parathyroid Hormone-Related Protein/Parathyroid Hormone Receptor 1 Signaling in Cancer and Metastasis.
Zhao Y; Su S; Li X
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046642
[TBL] [Abstract][Full Text] [Related]
37. Functional modulation of PTH1R activation and signaling by RAMP2.
Nemec K; Schihada H; Kleinau G; Zabel U; Grushevskyi EO; Scheerer P; Lohse MJ; Maiellaro I
Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2122037119. PubMed ID: 35914163
[TBL] [Abstract][Full Text] [Related]
38. Parathyroid Hormone 1 Receptor Signaling in Dental Mesenchymal Stem Cells: Basic and Clinical Implications.
Lyu P; Li B; Li P; Bi R; Cui C; Zhao Z; Zhou X; Fan Y
Front Cell Dev Biol; 2021; 9():654715. PubMed ID: 34760881
[TBL] [Abstract][Full Text] [Related]
39. Proteolytic Regulation of Parathyroid Hormone-Related Protein: Functional Implications for Skeletal Malignancy.
Frieling JS; Lynch CC
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181800
[TBL] [Abstract][Full Text] [Related]
40. Parathyroid hormone-related protein induces fibronectin up-regulation in rat mesangial cells through reactive oxygen species/Src/EGFR signaling.
Chen HM; Dai JJ; Zhu R; Peng FF; Wu SZ; Yu H; Krepinsky JC; Zhang BF
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30926678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
